| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Cue Biopharma, Inc. | Director | Common Stock | 1M | $2.76M | $2.76 | Jun 5, 2024 | By Park City Capital Offshore Master, Ltd. |
| Cue Biopharma, Inc. | Director | Common Stock | 100K | $276K | $2.76 | Jun 5, 2024 | By MF Capital Partners, LLC |
| Cue Biopharma, Inc. | Director | Stock Option (right to buy) | 48.8K | Jun 5, 2024 | Direct | ||
| Resonant Inc | Director | Common Stock | 0 | $4.50 | Mar 28, 2022 | By Park City Capital Offshore Master, Ltd. | |
| Resonant Inc | Director | Common Stock | 0 | $4.50 | Mar 28, 2022 | Direct | |
| Resonant Inc | Director | Restricted Stock Units | 0 | $4.50 | Mar 28, 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| CUE | Cue Biopharma, Inc. | Jun 5, 2024 | 1 | $0 | 4 | Jun 7, 2024 | Director |
| CUE | Cue Biopharma, Inc. | Jun 5, 2024 | 0 | $0 | 3 | Jun 7, 2024 | Director |
| RESN | Resonant Inc | Mar 28, 2022 | 5 | -$10M | 4 | Mar 28, 2022 | Director |
| RESN | Resonant Inc | Jun 7, 2021 | 5 | $0 | 4 | Jun 9, 2021 | Director |
| RESN | Resonant Inc | May 10, 2021 | 1 | $0 | 4 | May 12, 2021 | Director |